v2.4.0.6

Other Consolidated Financial Statement Detail (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Other income (expense), net |
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
(In millions) | 2012 |  | 2011 |  | 2012 |  | 2011
Interest income | $ | 5.9 |  |  | $ | 5.3 |  |  | $ | 22.6 |  |  | $ | 13.3 |
Interest expense | (8.7 | ) |  | (7.9 | ) |  | (23.1 | ) |  | (25.5 | )
Impairments of investments | (3.5 | ) |  | (0.8 | ) |  | (4.8 | ) |  | (7.6 | )
Gain (loss) on investments, net | 1.3 |  |  | (0.1 | ) |  | 15.6 |  |  | 15.4 |
Foreign exchange gains (losses), net | 0.1 |  |  | (4.8 | ) |  | 0.2 |  |  | (5.8 | )
Other, net | 0.4 |  |  | 0.6 |  |  | 3.1 |  |  | 0.7 |
Total other income (expense), net | $ | (4.5 | ) |  | $ | (7.7 | ) |  | $ | 13.5 |  |  | $ | (9.5 | )
Accrued Expenses and Other |
(In millions) | As of September 30, 2012 |  | As of December 31, 2011
Employee compensation and benefits | $ | 198.7 |  |  | $ | 176.3 |
Revenue-related rebates | 160.2 |  |  | 115.0 |
Deferred revenue | 140.6 |  |  | 69.6 |
Collaboration expenses | 46.6 |  |  | 44.2 |
Clinical development expenses | 52.9 |  |  | 40.8 |
Royalties and licensing fees | 45.3 |  |  | 47.4 |
Current portion of contingent consideration obligations | 21.3 |  |  | 10.8 |
Other | 200.6 |  |  | 173.1 |
Total accrued expenses and other | $ | 866.2 |  |  | $ | 677.2 |

X
- Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration